To validate this correlation of anticancer activities by the compounds with SULT1A1 expression, we tested the effects of RITA, AF, and ONC-1 in nine cancer cell lines with different SULT1A1 levels (Fig. 2b). The gene discussed is SULT1A1; the disease is cancer.